Back to Akre Capital Management LLC Akre Capital Management LLC

SOPHSOPH

Showing 8 of 10 quarters

Position history for Akre Capital Management LLCAkre Capital Management LLC's holdings in SOPHiA GENETICS SA

Yes. Akre Capital Management holds 3,719,140 shares of SOPH (SOPHiA GENETICS), worth $21.5M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Akre Capital Management has held SOPH since Q1 2024, across 10 quarterly 13F filings. SOPH is 0.4% of Akre Capital Management's reported 13F portfolio.

Current Value

$21.5M

Current Shares

3.7M

Total Value Change

+$13.3M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
3.7M
0.0%
$21.5M0.4%$5.77
0
2026-Q1
Unchanged
3.7M
0.0%
$18.4M0.3%$4.10
0
2025-Q4
Unchanged
3.7M
0.0%
$17.4M0.2%$4.73
0
2025-Q3
Unchanged
3.7M
0.0%
$17.7M0.2%$4.43
0
2025-Q2
Increased
3.7M
+66.2%
$11.5M0.1%$3.09
52
2025-Q1
Unchanged
2.2M
0.0%
$7.4M0.1%$3.26
0
2024-Q4
Unchanged
2.2M
0.0%
$6.9M0.1%$3.11
0
2024-Q3
Increased
2.2M
+16.5%
$8.2M0.1%$3.73
35

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used